Financials
- Market Capitalization 861.8915 M
- Employee 66
- Founded 2018
- CEO N/A
- Website www.latigobio.com
- Headquarter Delaware, United States
- FIGI BBG01LGT3SL3
- Industry N/A
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2430 | ZYN PTL LTD Class A Ordinary Shares | 10.18 USD | -1.64% | +11.87% | +17.69% | +17.69% | 992.42 M USD | ||
| 2449 | SPTX Seaport Therapeutics, Inc. Common Stock | 18.05 USD | -1.47% | -8.38% | -8.56% | -14.05% | 966.23 M USD | ||
| 2529 | FRBT Forbright, Inc. Class A Common Stock | 16.69 USD | -2.45% | -13.39% | -1.82% | -4.63% | 847.26 M USD | ||
| 2548 | ODTX Odyssey Therapeutics, Inc. Common Stock | 16.96 USD | -7.52% | -10.12% | -9.98% | -15.20% | 815.23 M USD |
Frequently asked questions about Latigo Biotherapeutics, Inc. Common Stock
What is the Latigo Biotherapeutics, Inc. Common Stock stock price today?
The current price of Latigo Biotherapeutics, Inc. Common Stock (LTGO) is 13.0000. Over the past 24 hours, the stock has changed by -1.81%. Follow the LTGO chart for real-time price dynamics.
What is the stock ticker of Latigo Biotherapeutics, Inc. Common Stock?
Latigo Biotherapeutics, Inc. Common Stock trades under the ticker LTGO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Latigo Biotherapeutics, Inc. Common Stock stock going up?
LTGO has changed by +0.08% over the last week, -20.54% over the last month, and -38.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Latigo Biotherapeutics, Inc. Common Stock?
Latigo Biotherapeutics, Inc. Common Stock currently has a market capitalization of 861.89 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Latigo Biotherapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Latigo Biotherapeutics, Inc. Common Stock reported earnings of -0.55 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Latigo Biotherapeutics, Inc. Common Stock revenue for the last quarter?
Latigo Biotherapeutics, Inc. Common Stock reported quarterly revenue of -4.58 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Latigo Biotherapeutics, Inc. Common Stock net income for the last quarter?
Latigo Biotherapeutics, Inc. Common Stock reported net income of -20.95 M for the last quarter. The previous quarter showed -25.8 M, which means net income changed by +18.79%.
How many employees does Latigo Biotherapeutics, Inc. Common Stock have?
As of the latest available data, Latigo Biotherapeutics, Inc. Common Stock has 66 employees. Workforce size can provide additional context about the company's scale and operations.
What is Latigo Biotherapeutics, Inc. Common Stock EBITDA?
Latigo Biotherapeutics, Inc. Common Stock EBITDA is -18.25 M, and its EBITDA margin is 398.34%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Latigo Biotherapeutics, Inc. Common Stock stock?
You can buy Latigo Biotherapeutics, Inc. Common Stock (LTGO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Latigo Biotherapeutics, Inc. Common Stock stock?
Investing in Latigo Biotherapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LTGO chart and related analysis on metatrader.com as part of your research.